CJ
GILD icon

Caitlin John’s Gilead Sciences GILD Stock Holding History

Caitlin John’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.6K Sell
349
-98
-22% -$13.7K 0.03% 314
2025
Q4 		$54.9K Buy
447
+102
+30% +$12.4K 0.04% 297
2025
Q3 		$38.3K Buy
+345
New +$39.2K 0.03% 304
2025
Q1 		– Sell
-338
Closed -$31.2K – 380
2024
Q4 		$31.2K Buy
338
+3
+0.9% +$270 0.02% 303
2024
Q3 		$31.1K Buy
335
+3
+0.9% +$229 0.02% 309
2024
Q2 		$22.8K Sell
332
-5
-1% -$334 0.02% 343
2024
Q1 		$24.7K Buy
337
+2
+0.6% +$154 0.02% 332
2023
Q4 		$27.1K Buy
+335
New +$26.1K 0.02% 297

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Caitlin John's GILD Position: Q1 2026 in Review

Caitlin John reduced its Gilead Sciences (GILD) stake by 22% in Q1 2026, selling an estimated $13.7K and leaving 349 shares worth $48.6K. The position accounts for 0.03% of the portfolio, ranked #314.

Caitlin John first reported a position in GILD in Q4 2023 and has held it in 8 quarters since. The position peaked at $54.9K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Caitlin John held 349 shares of Gilead Sciences worth $48.6K as of Q1 2026.
  • Caitlin John sold 98 Gilead Sciences shares in Q1 2026, an estimated $13.7K.
  • Gilead Sciences made up 0.03% of Caitlin John's portfolio in Q1 2026, its #314 holding.
  • Caitlin John first reported a position in Gilead Sciences in Q4 2023 and has held it in 8 quarters since.
  • Caitlin John's Gilead Sciences position peaked at $54.9K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.